hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review - Wikidata - awgldk - TriplyDB

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review

http://www.wikidata.org/entity/Q26862139

about

How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion The Clinical Significance of Phosphorylated Heat Shock Protein 27 (HSPB1) in Pancreatic Cancer Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery.Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters.Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine.Drug metabolism and pancreatic cancer.Functional characterization of human equilibrative nucleoside transporter 1.Sclareolide enhances gemcitabine‑induced cell death through mediating the NICD and Gli1 pathways in gemcitabine‑resistant human pancreatic cancer.Individualized radiotherapy (iRT) concepts for locally advanced pancreatic cancer (LAPC): indications and prognostic factors.Radioimmunotherapy--a potential novel tool for pancreatic cancer therapy?Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK.Nucleoside analogs: ready to enter the era of precision medicine?The role of the equilibrative nucleoside transporter 1 on tissue and fetal distribution of ribavirin in the mouse.Case of Six-Year Disease-Free Survival with Undifferentiated Carcinoma of the Pancreas.Epstein-Barr virus-targeted therapy in nasopharyngeal carcinoma.FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1.Astaxanthin inhibits gemcitabine-resistant human pancreatic cancer progression through EMT inhibition and gemcitabine resensitization.Future role of endoscopic ultrasound in personalized management of pancreatic cancer.Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.Low MUC4 expression is associated with survival benefit in patients with resectable pancreatic cancer receiving adjuvant gemcitabine.Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations.Irreversible electroporation enhances delivery of gemcitabine to pancreatic adenocarcinoma.

P2860

Q24273350-1A3C8C66-2912-493D-8202-10DBDD481A79 Q26775135-E00E3938-87DC-4955-ABD6-0C600C522EA7 Q33766617-848DDBF7-47AA-4E01-9AE2-0ED408333F50 Q33803923-49D13F16-AA0A-4256-B59B-65DB8A4A7DE2 Q35788344-767D8DB0-BBDE-4862-A05E-FD2FA2E8B750 Q36342657-B5F9CCD6-0280-40F5-85C7-A4DDA2162545 Q37542844-A83EDC39-8FB8-4F66-90EF-B5AA0CC85D4F Q37712414-67F5B6F2-FE59-4DB4-A389-4D426AB36B0B Q37720259-D944DA83-4302-4EEB-B5C9-48BD25F9E7EE Q38413842-22926D89-7BB6-4CBB-A24C-54D979BB57EC Q38450531-358B4066-8946-4F0D-8E65-FC7CDA1528B7 Q38707179-981CE3BA-E3F5-41C3-9CC6-7D2C596EBC48 Q38718324-31FBAF11-C97A-47BB-8CB5-52B9E946CEE8 Q38842938-A01C027D-AC22-4F46-B097-9115BACEC0E1 Q40668772-E5D68DF7-B385-4848-A212-C9E70A8BDB70 Q41237372-4CC168D9-2DBE-4D96-8580-A4ADBF076A21 Q42145376-A75440F3-8F8E-4A9C-84FE-E67E96CD1DBB Q43235785-5E6C335F-67DE-43EF-BA21-C719853A6B10 Q47128811-B1AB7BA3-6AFE-4C3E-B7E7-AB2EA50BC1C2 Q47138141-A2F8B195-9DA1-41D6-9F82-3A49C540FF8E Q47339502-DCBB9884-F48C-451E-8551-6793259EC259 Q51107700-4C45CDA4-FAE5-4CE0-804F-C15F73925AF3 Q52646480-3ABC3256-66F8-488B-9F87-0C3B2BF503BC Q52860471-25F0D023-39FA-4A88-A34A-976CDB3F37DB

P2860

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review

http://www.wikidata.org/entity/Q26862139

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

hENT1 expression is predictive ...... ic cancer: a systematic review

@ast

hENT1 expression is predictive ...... ic cancer: a systematic review

@en

hENT1 expression is predictive ...... ic cancer: a systematic review

@nl

type

label

hENT1 expression is predictive ...... ic cancer: a systematic review

@ast

hENT1 expression is predictive ...... ic cancer: a systematic review

@en

hENT1 expression is predictive ...... ic cancer: a systematic review

@nl

prefLabel

hENT1 expression is predictive ...... ic cancer: a systematic review

@ast

hENT1 expression is predictive ...... ic cancer: a systematic review

@en

hENT1 expression is predictive ...... ic cancer: a systematic review

@nl

P1433

Q26862139-F09F4EAA-10F4-4980-8444-FFAE70E490F6

P1476

Q26862139-F97677DB-85EC-41F4-9CB3-4E03748A10DA

P2093

Q26862139-52C1BC36-9C29-44EB-84AE-D6D3EA1A2A18

P2860

Q26862139-058FDEE7-D016-42E0-96C5-559EAE191775

Q26862139-0FCDD3C7-7CA5-4A7D-A7B6-00FE626FD576

Q26862139-18EB5301-8C6B-4B4C-B9E9-05E66BB9D8FF

Q26862139-1AC66235-6F7A-4705-AB54-9A1829B32823

Q26862139-2E34D768-823F-431A-ACFF-1D3CC73CDB88

Q26862139-316A0462-E5B8-4853-84AC-B5768783CA86

Q26862139-36624AF0-8AFD-4CF4-93F5-38ECA6C57774

Q26862139-3C70C7F7-ACED-4CA4-8D18-03D05E37B01A

Q26862139-64B565F4-DD64-4D83-A929-1434361CF446

Q26862139-7343A374-087C-4B1C-8CCF-0B01D8D50D1C

P304

Q26862139-0718D073-530D-4001-8B60-220F5B1B8651

P31

Q26862139-21CF38E5-96C3-43F8-80BA-0FA16C4E7432

Q26862139-7479E515-FDD3-400A-AA52-D56F6BC6A52E

P3181

Q26862139-93F5F391-773A-4D5D-8D96-C8632E12B852

P356

Q26862139-A82C0368-6D6A-42C0-88E6-A694DDF76E2E

P407

Q26862139-AE01C30A-F901-4F41-9F05-1B693D3867BB

P433

Q26862139-E0BBA351-FA4B-4649-ADEF-FB4CE0BE1B0B

P478

Q26862139-02B95F3E-4FB8-4BE3-8FAA-D80AC396FFCF

P577

Q26862139-4F8784A6-2C25-40AF-AED9-03AAD5AEAC66

P698

Q26862139-0A4583C5-8044-4F79-93F5-230644233B1F

P932

Q26862139-5FAB1BB1-5907-4895-B147-5DB692BAEE68

P3181

P356

WJG.V20.I26.8482

P1433

World Journal of Gastroenterology

P1476

hENT1 expression is predictive ...... ic cancer: a systematic review

@en

P2093

Stina Nordh

http://www.w3.org/2001/XMLSchema#string

P2860

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

P304

8482-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

4448910

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.V20.I26.8482

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25024604

http://www.w3.org/2001/XMLSchema#string

P932

4093699

http://www.w3.org/2001/XMLSchema#string